Blog
Perspectives on medical affairs, MSL workflows, and source-grounded AI
Written by the Argon AI team. Topics include MSL field preparation, label change management, medical information workflows, knowledge repository design, and responsible AI adoption in regulated pharmaceutical environments.
How MSLs Prepare for HCP Meetings Without Spending Half the Day in PDFs
A walkthrough of the document retrieval problem medical science liaisons face before every key opinion leader meeting, and how structured source-grounded Q&A changes the preparation workflow.
Why Source Grounding Matters More in Pharma Than in Any Other Industry
When an AI system gives a confident wrong answer about a drug's dosing in a scientific exchange, the downstream risk is not an embarrassment. It is a regulatory event.
Label Changes Happen Faster Than Most MSL Teams Realize
FDA labeling updates can invalidate talking points MSLs have been using for months. The gap between when a label changes and when a field team knows about it is a compliance risk hiding in plain sight.
The MSL Knowledge Problem Is Not About Memorization
Medical science liaisons are highly trained scientists. The problem is not that they do not know the data. The problem is that retrieval from fragmented document stores takes longer than the time available.
Building a Medical Affairs Knowledge Repository Before a Drug Launch
In the months before a commercial launch, medical affairs teams accumulate hundreds of documents. What happens when an MSL needs to find something in that stack on day one?
AI-Assisted Retrieval in Medical Information Request Workflows
Medical information departments handle thousands of inbound requests per year. Each one requires locating the right source document, confirming the data is current, and drafting a citable response.
Scientific Exchange at Scale: What Changes When MSL Teams Can Retrieve Faster
When the bottleneck in scientific exchange moves from retrieval to synthesis, the nature of MSL conversations with physicians changes. Faster access to source data means more time for the exchange itself.
How Medical Affairs Teams Track FDA and EMA Regulatory Updates
Regulatory intelligence is not just a job for regulatory affairs. When FDA issues a labeling guidance, medical affairs teams need to know what it means for their current messaging and field materials.
Connecting Publication Strategy to MSL Field Execution
A published Phase III trial is a strategic asset. But the path from a journal publication landing in PubMed to an MSL confidently discussing it with a prescriber involves more steps than most realize.
What to Ask a Knowledge Platform Vendor About Data Privacy in Pharma
Medical affairs teams are uploading clinical study reports, investigator brochures, and unpublished label drafts into software platforms. Here are the data-handling questions that matter before signing.
Preparing for Formulary Reviews: How Medical Affairs Supports Payer Dialogues
Formulary committee meetings require rapid access to comparative efficacy data, safety profiles, and real-world evidence. Medical affairs teams increasingly own the scientific narrative in these settings.
A Framework for Responsible AI Adoption in Medical Affairs
Adopting AI tools in regulated medical affairs is not a technology decision. It is a governance decision. What validation, oversight, and accountability structures should be in place before deployment.
Ready to see Argon in action?
Schedule a 30-minute demo. We will use your actual document types and show you what retrieval looks like on clinical study reports, label PDFs, and internal publications.